This is a draft version - Page is not published

Equity Capital Markets

Protagonist Therapeutics, Inc.

04/23
|
$100 Million
Protagonist
Piper Sandler served as bookrunner for Protagonist Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$621.00 Million
Acelyrin
Acelyrin, Inc.
Initial Public Offering
Active Bookrunner
$68.30 Million
Reneo
Reneo Pharmaceuticals
Confidentially Marketed Follow-On Offering
Active Bookrunner
$62.00 Million
Meira
MeiraGTx Holdings plc
PIPE
Joint Placement Agent
$22.80 Million
Gamida
Gamida Cell Ltd.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$100.00 Million
Protagonist
Protagonist Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$402.50 Million
FreshPet
FreshPet
Convertible Notes Offering
Co-Manager
$10.00 Million
Miromatrix
Miromatrix Medical Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$933.20 Million
Clearwater
Clearwater Analytics Holdings, Inc.
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$313.50 Million
Bumble
Bumble Trading Inc.
Confidentially Marketed Follow-on offering
Co-Manager
$195.00 Million
Clearwater
Clearwater Analytics
Follow-On Offering
Co-Manager
$30.00 Million
Minerva
Minerva Surgical Inc.
PIPE
Sole Placement Agent
$30.00 Million
galera
Galera Therapeutics
Registered Direct Offering
Sole Placement Agent
$140.90 Million
Xponential Fitness
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$241.50 Million
collegium
Collegium Pharmaceutical, Inc.
Convertible Offering
Sole Manager
$100.00 Million
Ellington Financial Inc
Preferred Stock Offering
Left Bookrunner
$500.00 Million
Integer Holdings Corporation
Convertible Debt Offering
Passive Bookrunner

© 2023 Piper Sandler Companies. Since 1895. All rights reserved.